Literature DB >> 25721917

Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults.

Júlia Cristina Cardoso Carraro1, Helen Hermana M Hermsdorff, Blanca Puchau, M Ángeles Zulet, Fermín I Milagro, Josefina Bressan, J Alfredo Martínez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25721917     DOI： 10.1007/s13105-015-0391-2

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN： 1138-7548            Impact factor:   4.158


× No keyword cloud information.
  46 in total

1.  A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects.

Authors:  Helen Hermana M Hermsdorff; M Ángeles Zulet; Itziar Abete; J Alfredo Martínez
Journal:  Eur J Nutr       Date:  2010-05-25       Impact factor: 5.614

Review 2.  Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis.

Authors:  Birgit Gustafson; Ann Hammarstedt; Christian X Andersson; Ulf Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-06       Impact factor: 8.311

3.  Postprandial variations of plasma inflammatory markers in abdominally obese men.

Authors:  Patricia Blackburn; Jean-Pierre Després; Benoît Lamarche; Angelo Tremblay; Jean Bergeron; Isabelle Lemieux; Charles Couillard
Journal:  Obesity (Silver Spring)       Date:  2006-10       Impact factor: 5.002

Review 4.  Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up.

Authors:  Joshua P Thaler; Michael W Schwartz
Journal:  Endocrinology       Date:  2010-06-23       Impact factor: 4.736

5.  Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin.

Authors:  Marie-Kathrin Breyer; Erica P A Rutten; Juanita H J Vernooy; Martijn A Spruit; Mieke A Dentener; Carla van der Kallen; Marleen M J vanGreevenbroek; Emiel F M Wouters
Journal:  Respir Med       Date:  2011-03-01       Impact factor: 3.415

6.  Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men.

Authors:  J Helmersson; A Larsson; B Vessby; S Basu
Journal:  Atherosclerosis       Date:  2005-04-26       Impact factor: 5.162

7.  Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline.

Authors:  M F McCarty
Journal:  Med Hypotheses       Date:  1999-05       Impact factor: 1.538

8.  IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition.

Authors:  Eduardo R Ropelle; Marcelo B Flores; Dennys E Cintra; Guilherme Z Rocha; José R Pauli; Joseane Morari; Claudio T de Souza; Juliana C Moraes; Patrícia O Prada; Dioze Guadagnini; Rodrigo M Marin; Alexandre G Oliveira; Taize M Augusto; Hernandes F Carvalho; Lício A Velloso; Mario J A Saad; José B C Carvalheira
Journal:  PLoS Biol       Date:  2010-08-24       Impact factor: 8.029

9.  The effects of resveratrol on tissue injury, oxidative damage, and pro-inflammatory cytokines in an experimental model of acute pancreatitis.

Authors:  Ahmet Gulcubuk; Damla Haktanir; Aris Cakiris; Duran Ustek; Ozlem Guzel; Muzaffer Erturk; Funda Yildirim; Ibrahim Akyazi; Hayriye Cicekci; Mehmet Hanifi Durak; Sema Sandikci-Altunatmaz; Kemal Altunatmaz
Journal:  J Physiol Biochem       Date:  2014-02-19       Impact factor: 4.158

Review 10.  Impact of oxygen availability on body weight management.

Authors:  P Quintero; F I Milagro; J Campión; J A Martínez
Journal:  Med Hypotheses       Date:  2009-11-12       Impact factor: 1.538
View more
  1 in total

1.  Inflammatory Biomarkers and Components of Metabolic Syndrome in Adolescents: a Systematic Review.

Authors:  Ariane R de F Rocha; Núbia de S Morais; Silvia E Priore; Sylvia do C C Franceschini
Journal:  Inflammation       Date:  2021-09-21       Impact factor: 4.092
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.